Governance Genscript Biotech Corporation

1548

KYG3825B1059

Biotechnology & Medical Research

Market Closed - Hong Kong S.E. Other stock markets 09:08:14 16/06/2026 BST			5-day change	1st Jan Change
11.48 ^HKD	-2.71%		-4.97%	-7.57%

06-15	Genscript Associate Reports Promising Phase 1 Data for LB2501 in B-Cell Lymphoma	MT
06-03	Genscript Associate to Present Data for Lymphoma Drug at European Conference; Shares Surge 11%	MT

Executive Committee: Genscript Biotech Corporation

Manager

Positions heldSince

Weihui Shao

Chief Executive Officer

31/12/2022

Ye Wang

57 year

Chief Operating Officer	31/03/2014
Founder	31/12/2001
President	30/11/2017

Jing Jing Hua

Comptroller/Controller/Auditor

Josie Zhou

Director of Finance/CFO

30/04/2025

Wai Yee Lam

50 year

Corporate Secretary

14/03/2026

Composition of the Board of Directors: Genscript Biotech Corporation

Director

CommitteesSince

Jian Ge Meng

57 year

Nominating Committee Chair

21/11/2020

Ye Wang

57 year

Compensation Committee	01/08/2022
Nominating Committee	10/03/2025
Audit Committee Chair	28/05/2025
Governance Committee Chair	01/08/2022
Nominating Committee Chair	01/08/2022

Yiu Leung Cheung

66 year

Compensation Committee	20/02/2024
Governance Committee	07/02/2021
Nominating Committee	11/04/2024
Audit Committee Chair	31/05/2025

John Quelch

74 year

Audit Committee	31/12/2024
Compensation Committee Chair
Compensation Committee	31/12/2024

Chenyang Shi

58 year

Nominating Committee	11/04/2024
Compensation Committee Chair	28/05/2025

Jiu An Pan

57 year

Audit Committee	25/11/2018
Nominating Committee	25/11/2018

Alphonse Galdes

73 year

Audit Committee

10/03/2025

Ross Allen Grossman

75 year

Compensation Committee

10/03/2025

Fang Liang Zhang

61 year

Director/Board Member

01/05/2022

Li Zhu

76 year

Director/Board Member

Latest Appointments: Genscript Biotech Corporation

03-15	Genscript Biotech Corporation Announces Company Secretary Changes, Effective March 15, 2026	CI
29/05/25	Genscript Biotech Corporation Announces Board and Committee Changes, Effective 29 May 2025	CI
11/03/25	Genscript Biotech Corporation Announces Board and Board Committee Changes	CI
09/02/25	Genscript Biotech Corporation Announces Establishment of A Sub-Committee of the Risk Management and ESG Committee	CI
02/12/24	Genscript Biotech's Rotating CEO Steps Down	MT
13/11/24	Genscript Biotech Corporation Appoints Aylin Kosova Bilgin Has Joined as the First-Ever Chief Marketing Officer for GenScript Life Science Group	CI
12/09/24	Genscript Biotech Corporation Announces Board Appointments	CI

More news

Former Officers and Directors: Genscript Biotech Corporation

Insider

Positions held

SinceUntil

Wai Ling Wong

Corporate Secretary

23/08/2015

14/03/2026

Lu Quan Wang

Director/Board Member	20/05/2015	28/05/2025
Founder	31/12/2001	28/05/2025

Zu Mian Dai

Director/Board Member	23/08/2015	28/05/2025
Independent Dir/Board Member	23/08/2015	28/05/2025

Jia Fen Wang

Director/Board Member

25/11/2018

04/07/2024

Xue Hai Wang

Director/Board Member	21/11/2020	04/07/2024
Independent Dir/Board Member	21/11/2020	04/07/2024

Yue Xin Pan

Director/Board Member

23/08/2015

20/06/2024

Hong Xin Guo

Director/Board Member	23/08/2015	20/06/2024
Independent Dir/Board Member	23/08/2015	20/06/2024

Zhenyu Liu

Chief Executive Officer	01/08/2020	31/12/2022
Corporate Officer/Principal	30/04/2009	01/08/2020

Liu Song Yin

Director/Board Member

28/02/2015

30/09/2020

Min Zhang

Director/Board Member	23/08/2015	25/11/2018
Independent Dir/Board Member	23/08/2015	25/11/2018

Zuie Chin Huang

Director/Board Member

23/08/2015

04/01/2018

Shiniu Wei

Director of Finance/CFO

Elaine Qian

Human Resources Officer

Simon Wu

Corporate Officer/Principal

Age distribution of managers

Parity Men Women

Male	11
Female	5

Of which Executive Committee

Male	0
Female	5

Of which Directors

Male	9
Female	1

Revisions

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Genscript Biotech Corp is an investment holding company principally engaged in the manufacture and sale of life science research products and services. The Company operates its businesses through five segments. The Life-science Services and Products segment provides comprehensive research services and products. The Biologics Development Services segment provides comprehensive services to help biopharmaceutical and biotech companies accelerate the development of therapeutic antibodies, and gene, cell therapy products with an integrated platform. The Industrial Synthetic Biology Products segment provides industrial enzyme development and production through non-pathogenic microbial strains constructed using genetic engineering. The Cell Therapy segment discovers and develops CAR-T therapies for the treatment of liquid and solid tumors. The Operation segment provides shared services to other segments. The Company mainly operates its businesses in the domestic and overseas markets.

Employees

6,165

Sector

Biotechnology & Medical Research

More about the company